Mabwell-b
2493.HK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.89B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9.89 Billion |
|---|---|
| Enterprise Value | $11.33 Billion |
| Earnings per Share | $-2.43 |
| Beta | 0.53 |
| Outstanding Shares | 445,537,831 |
Return
| Return on Equity | -146.76% |
|---|---|
| Return on Assets | -19.82% |
| Return on Invested Capital | -27.28% |
Valuation & Multiples
| P/E Ratio | -5.83 |
|---|---|
| PEG | -2.45 |
| Price to Sales | 17.8 |
| Price to Book Ratio | 8.9 |
| Enterprise Value to Revenue | 15.79 |
| Enterprise Value to EBIT | -12.2 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 5.25 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Mabwell-b
1,325 employees
CEO: Datao Liu
Mabwell (Shanghai) Bioscience Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of biological products for oncology, immunology, bone disorders, ophthalmology, hematology,...